Cutler Group LLC / CA - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$9
-10.0%
4,5000.0%0.00%0.0%
Q2 2023$10
-23.1%
4,5000.0%0.00%0.0%
Q1 2023$13
+30.0%
4,5000.0%0.00%0.0%
Q4 2022$10
-99.9%
4,500
-20.4%
0.00%0.0%
Q3 2022$9,000
-30.8%
5,652
-3.5%
0.00%0.0%
Q2 2022$13,000
-13.3%
5,858
-46.3%
0.00%0.0%
Q1 2022$15,000
-87.1%
10,900
-85.5%
0.00%
-80.0%
Q4 2021$116,000
+346.2%
75,204
+902.7%
0.01%
+400.0%
Q3 2021$26,000
+73.3%
7,500
+41.5%
0.00%0.0%
Q2 2021$15,000
-11.8%
5,300
+1.9%
0.00%0.0%
Q1 2021$17,000
-5.6%
5,2000.0%0.00%0.0%
Q4 2020$18,000
-10.0%
5,200
-76.9%
0.00%0.0%
Q3 2020$20,000
-20.0%
22,500
+44.2%
0.00%
-50.0%
Q1 2019$25,000
+1150.0%
15,600
+2500.0%
0.00%
Q4 2018$2,000
-91.3%
600
-96.2%
0.00%
-100.0%
Q3 2018$23,000
+666.7%
16,000
+3100.0%
0.00%
Q2 2018$3,000
+50.0%
500
-54.5%
0.00%
Q1 2018$2,000
-88.9%
1,100
-71.1%
0.00%
-100.0%
Q4 2017$18,000
+125.0%
3,800
+5.6%
0.00%
Q3 2017$8,000
+33.3%
3,600
-41.0%
0.00%
Q2 2017$6,000
-93.6%
6,100
-81.5%
0.00%
-100.0%
Q1 2017$94,000
+168.6%
33,051
-20.7%
0.00%
+300.0%
Q4 2016$35,000
-5.4%
41,664
+116.1%
0.00%0.0%
Q3 2016$37,000
-9.8%
19,280
+12.2%
0.00%
-50.0%
Q2 2016$41,000
-19.6%
17,180
+23.8%
0.00%
-33.3%
Q1 2016$51,000
+30.8%
13,880
+63.7%
0.00%
+50.0%
Q4 2015$39,0008,4800.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Whitefort Capital Management, LP 11,895,477$24,147,81812.66%
Two Seas Capital LP 8,280,818$16,810,0613.38%
FourWorld Capital Management LLC 1,341,907$2,724,0710.51%
Tejara Capital Ltd 180,077$365,5560.21%
Woodline Partners LP 4,719,903$9,581,4030.11%
Hudson Bay Capital Management LP 8,299,808$16,848,6100.07%
Kepos Capital LP 155,691$3160.06%
Virtus ETF Advisers LLC 40,040$81,2810.05%
Centiva Capital, LP 1,071,705$2,175,5610.05%
Kades & Cheifetz LLC 20,000$40,6000.03%
View complete list of ARBUTUS BIOPHARMA CORP shareholders